This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Coleman, A. E. Articles by Janz, S. Search for Related Content PubMed PubMed Citation Articles by Coleman, A. E. Articles by Janz, S.

Previously Hidden Chromosome Aberrations in T(12;15)-positive BALB/c Plasmacytomas Uncovered by Multicolor Spectral Karyotyping

Laboratory of Genetics, Division of Basic Sciences, National Cancer Institute, NIH, Bethesda, Maryland 20892-4255 [A. E. C., S. J.]; Genome Technology Branch, National Human Genome Research Institute, NIH, Bethesda, Maryland 20892-4470 [E. S., Z. W., S. d. M., T. R.]; and Department of Pathology, Cambridge University, Cambridge CB2 1QP, United Kingdom [F. Y., M. A. F-S.]

The majority of BALB/c mouse plasmacytomas harbor a balanced T(12;15) chromosomal translocation deregulating the expression of the proto-oncogene c-myc. Recent evidence suggests that the T(12;15) is an initiating tumorigenic mutation that occurs in early plasmacytoma precursor cells. However, the possible contribution of additional chromosomal aberrations to the progression of plasmacytoma development has been largely ignored. Here we use multicolor spectral karyotyping (SKY) to evaluate 10 established BALB/c plasmacytomas in which the T(12;15) had been previously detected by G banding. SKY readily confirmed the presence of this translocation in all of these tumors and in three plasmacytomas newly identified secondary cytogenetic changes of the c-myc-deregulating chromosome (Chr) T(12;15). In addition, numerous previously unknown aberrations were found to be scattered throughout the genome, which was interpreted to reflect the general genomic instability of plasmacytomas. Instability of this sort was not uniform, however, because only half of the tumors were heavily rearranged. Seven apparent hot spots of chromosomal rearrangements (40% incidence) were identified and mapped to Chrs 1B, 1G-H, 2G-H1, 4C7-D2, 12D, 14C-D2, and XE-F1. Two of these regions, Chr 1B and Chr 4C7-D2, are suspected to harbor plasmacytoma susceptibility loci; Pctr¹ and Pctr² on Chr 4C7-D2 and as yet unnamed loci on Chr 1B. These results suggest that secondary chromosomal rearrangements contribute to plasmacytoma progression in BALB/c mice. To evaluate the biological significance of these rearrangements, SKY will be used in follow-up experiments to search for the presence of recurrent and/or consistent secondary cytogenetic aberrations in primary BALB/c plasmacytomas.

¹ To whom requests for reprints should be addressed, at Laboratory of Genetics, National Cancer Institute, 37 Center Drive, Bethesda, MD 20892-4255. Phone: (301) 496-2628; Fax: (301) 402-1031; E-mail: janzs@dc37a.nci.nih.gov.

Received 5/ 2/97. Accepted 8/15/97.

This article has been cited by other articles:

				K. Felix, A. Polack, W. Pretsch, S. H. Jackson, L. Feigenbaum, G.-W. Bornkamm, and S. Janz Moderate Hypermutability of a Transgenic lacZ Reporter Gene in Myc-Dependent Inflammation-Induced Plasma Cell Tumors in Mice Cancer Res., January 15, 2004; 64(2): 530 - 537. [Abstract] [Full Text] [PDF]

				S. Silva, A. L. Kovalchuk, J. S. Kim, G. Klein, and S. Janz BCL2 Accelerates Inflammation-induced BALB/c Plasmacytomas and Promotes Novel Tumors with Coexisting T(12;15) and T(6;15) Translocations Cancer Res., December 15, 2003; 63(24): 8656 - 8663. [Abstract] [Full Text] [PDF]

				L. M. Sargent, J. R. Senft, D. T. Lowry, A. M. Jefferson, F. L. Tyson, A. M. Malkinson, A. E. Coleman, and S. H. Reynolds Specific Chromosomal Aberrations in Mouse Lung Adenocarcinoma Cell Lines Detected by Spectral Karyotyping: A Comparison with Human Lung Adenocarcinoma Cancer Res., February 1, 2002; 62(4): 1152 - 1157. [Abstract] [Full Text] [PDF]

				A. E. Coleman, A. L. Kovalchuk, S. Janz, A. Palini, and T. Ried Jumping Translocation Breakpoint Regions Lead to Amplification of Rearranged Myc Blood, June 15, 1999; 93(12): 4442 - 4444. [Full Text] [PDF]

				D. W. Felsher and J. M. Bishop Transient excess of MYC activity can elicit genomic instability and tumorigenesis PNAS, March 30, 1999; 96(7): 3940 - 3944. [Abstract] [Full Text] [PDF]